Veraguensin

CAS No. 19950-55-1

Veraguensin( —— )

Catalog No. M29056 CAS No. 19950-55-1

Veraguensin is derived from Magnolia sp.. Veraguensin inhibits bone resorption and shows high antileishmanial activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 180 In Stock
10MG 297 In Stock
25MG 502 In Stock
50MG 699 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Veraguensin
  • Note
    Research use only, not for human use.
  • Brief Description
    Veraguensin is derived from Magnolia sp.. Veraguensin inhibits bone resorption and shows high antileishmanial activity.
  • Description
    Veraguensin is derived from Magnolia sp.. Veraguensin inhibits bone resorption and shows high antileishmanial activity.(In Vitro):Veraguensin shows activity against trypomastigote T. cruzi.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19950-55-1
  • Formula Weight
    372.461
  • Molecular Formula
    C22H28O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (67.12 mM)
  • SMILES
    COc1ccc(cc1OC)[C@H]1O[C@H]([C@@H](C)[C@@H]1C)c1ccc(OC)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NJK14047

    NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.

  • Antimicrobial agent-...

    Antimicrobial agent-21 is a potent mitogen activated protein kinase inhibitor with antibacterial, anti-inflammatory and antitumor activity for the treatment of cataracts, ulcerative colitis, meningitis and Kawasaki's disease and Parkinson's disease.

  • AZD-7624

    AZD-7624 is a potent, selective, inhaled p38α MAPK inhibitor with pIC50 of 10.0.